In a world where sepsis kills 270,000 Americans annually, Inflammatix is turning the immune system into a diagnostic computer. They're not just reading vital signs—they're decoding the body's own defense code to tell doctors, within minutes, whether an infection is bacterial, viral, or something else entirely.

"They're not competing with traditional labs—they're making them obsolete for acute care decisions."

The traffic data reveals something fascinating: 530 monthly searches for 'inflammatix' itself, plus 450 for 'inflammatix strem-1'—their proprietary biomarker. This isn't just brand awareness; it's clinical community engagement. When clinicians and researchers are searching for your specific biomarker by name, you've achieved thought leadership in the space. The 47% direct traffic is particularly telling—this is a destination site for people who already know what they're looking for.

• HostDx™ technology reads immune gene expression patterns, not just pathogens
• Point-of-care format delivers results in 30 minutes vs. 24-48 hours for traditional cultures
• Dual focus: sepsis triage + antibiotic stewardship addresses two massive healthcare pain points
• Strong academic pedigree—co-founder Purvesh Khatri is a Stanford professor with deep immune informatics expertise